These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19363778)

  • 1. Pathogenesis of secondary hyperparathyroidism.
    Cozzolino M; Pasho S; Fallabrino G; Olivi L; Gallieni M; Brancaccio D
    Int J Artif Organs; 2009 Feb; 32(2):75-80. PubMed ID: 19363778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology of calcium and phosphate metabolism impairment in chronic kidney disease.
    Cozzolino M; Ciceri P; Volpi EM; Olivi L; Messa PG
    Blood Purif; 2009; 27(4):338-44. PubMed ID: 19295196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.
    Gutierrez O; Isakova T; Rhee E; Shah A; Holmes J; Collerone G; Jüppner H; Wolf M
    J Am Soc Nephrol; 2005 Jul; 16(7):2205-15. PubMed ID: 15917335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of α-klotho, fibroblast growth factor-, vitamin-D and calcium-sensing receptor in 70 patients with secondary hyperparathyroidism.
    Latus J; Lehmann R; Roesel M; Fritz P; Braun N; Ulmer C; Steurer W; Biegger D; Ott G; Dippon J; Alscher MD; Kimmel M
    Kidney Blood Press Res; 2013; 37(1):84-94. PubMed ID: 23552627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options.
    Cunningham J; Locatelli F; Rodriguez M
    Clin J Am Soc Nephrol; 2011 Apr; 6(4):913-21. PubMed ID: 21454719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging topics in pediatric bone and mineral disorders 2008.
    McKay CP; Portale A
    Semin Nephrol; 2009 Jul; 29(4):370-8. PubMed ID: 19615558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary Hyperparathyroidism: Pathogenesis and Latest Treatment.
    Mizobuchi M; Ogata H; Koiwa F
    Ther Apher Dial; 2019 Aug; 23(4):309-318. PubMed ID: 30411503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The pathophysiology of secondary hyperparathyroidism].
    Tokumoto M
    Clin Calcium; 2016 Jun; 26(6):821-9. PubMed ID: 27230837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcimimetics or vitamin D analogs for suppressing parathyroid hormone in end-stage renal disease: time for a paradigm shift?
    Wetmore JB; Quarles LD
    Nat Clin Pract Nephrol; 2009 Jan; 5(1):24-33. PubMed ID: 18957950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Frontiers in vitamin D; basic research and clinical application. Vitamin D and secondary hyperparathyroidism].
    Tanaka H; Komaba H; Fukagawa M
    Clin Calcium; 2011 Nov; 21(11):27-34. PubMed ID: 22040818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
    Koizumi M; Komaba H; Fukagawa M
    Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased parathyroid expression of klotho in uremic rats.
    Hofman-Bang J; Martuseviciene G; Santini MA; Olgaard K; Lewin E
    Kidney Int; 2010 Dec; 78(11):1119-27. PubMed ID: 20631679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of evocalcet on parathyroid calcium-sensing receptor and vitamin D receptor expression in uremic rats.
    Saito T; Mizobuchi M; Sakai M; Kawata T; Kitayama T; Kato T; Suzuki T; Ogata H; Koiwa F; Honda H
    FASEB J; 2023 Aug; 37(8):e23094. PubMed ID: 37462513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermethylation of the CaSR and VDR genes in the parathyroid glands in chronic kidney disease rats with high-phosphate diet.
    Uchiyama T; Tatsumi N; Kamejima S; Waku T; Ohkido I; Yokoyama K; Yokoo T; Okabe M
    Hum Cell; 2016 Oct; 29(4):155-61. PubMed ID: 27589858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New insights in the pathogenesis of secondary hyperparathyroidism].
    Cozzolino M; Butti A; Chiarelli G; Rocca-Rey L; Bellasi A; Galassi A; Gallieni M; Brancaccio D
    G Ital Nefrol; 2005; 22(4):329-36. PubMed ID: 16267793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of calcium-sensing receptor and vitamin d receptor in the pathophysiology of secondary hyperparathyroidism.
    McCann LM; Beto J
    J Ren Nutr; 2010 May; 20(3):141-50. PubMed ID: 20303786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathophysiology of secondary hyperparathyroidism: the role of FGF23 and Klotho].
    Mazzaferro S; Pasquali M; Tartaglione L; Rotondi S; Pirrò G
    G Ital Nefrol; 2009; 26 Suppl 49():S11-7. PubMed ID: 19941273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of decreased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathyroidism.
    Yano S; Sugimoto T; Tsukamoto T; Chihara K; Kobayashi A; Kitazawa S; Maeda S; Kitazawa R
    Kidney Int; 2000 Nov; 58(5):1980-6. PubMed ID: 11044218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.
    Torres PU
    J Ren Nutr; 2006 Jul; 16(3):253-8. PubMed ID: 16825031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.